TITLE

Sequenom tests face questions

AUTHOR(S)
Slowik, Elizabeth
PUB. DATE
August 2010
SOURCE
Grand Rapids Business Journal;8/2/2010, Vol. 28 Issue 32, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that San Diego, California-based Sequenom Inc. is preparing to respond to the U.S. Food and Drug Administration's (FDA) review of its genetic tests being conducted in Grand Rapids, Michigan, including fetal Rhesus D genotyping and fetal sex determination.
ACCESSION #
52943835

 

Related Articles

  • The Testing of the Tests: FDA seeks to regulate genetic tests more actively, while encouraging diagnostic development. Wechsler, Jill // Pharmaceutical Executive;Sep2010, Vol. 30 Issue 9, p18 

    The article focuses on the concerns by the U.S. Food and Drug Administration (FDA) regarding the direct-to-consumer (DTC) marketing of laboratory-developed tests (LDTs). It notes that the proliferation of more complex tests such as genetic test kits marketed directly to consumers is prompting...

  • Pathway Genomics Obtains FDA Registration.  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p268 

    The article reports on the classification and registration of Pathway Genomics Corp.'s proprietary saliva collection kit as a Class I exempt device approved by the U.S. Food & Drug Administration (FDA). It notes that the kit helps patients and physicians with an effective and safe method of...

  • FDA reopens DTC gene test comment period.  // Medical Device Daily;4/8/2011, Vol. 15 Issue 68, p7 

    The article reports on the decision of the U.S. Food and Drug Administration (FDA) to reopen the comment period for its proposal to implement regulatory requirements on companies that are offering direct-to-consumer genetic tests in April 2011.

  • FDA resists regulatory role in gene tests. Wadman, Meredith // Nature;11/14/1996, Vol. 384 Issue 6605, p101 

    Discusses the controversy surrounding the decision by a government-sponsered task force to recommend that the US Food and Drug Administration (FDA) regulate genetic tests. The task force comprised of the National Institutes of Health and the Department of Energy Task Force on Genetic Testing;...

  • FDA: Gene Tests Need Premarket Approval. Kuehn, Bridget M. // JAMA: Journal of the American Medical Association;7/14/2010, Vol. 304 Issue 2, p145 

    The article focuses on the need for manufacturers or marketers of direct-to-consumer gene tests to submit their products for premarketing review and approval by the U.S. Food and Drug Administration (FDA). A series of warning letters was sent by the agency in May and June 2010 to companies...

  • FDA CLEARS FIRST GENETIC LAB TEST.  // Materials Management in Health Care;Feb2005, Vol. 14 Issue 2, p7 

    This article reports that the U.S. Food and Drug Administration (FDA) has cleared a new product for market that purports to make determining the right medication and dosage a little easier for patients with certain conditions. The AmliChip CYP450 Test, manufactured by Roche, Indianapolis, allows...

  • THE OPTIMAL SCOPE OF FDA REGULATION OF GENETIC TESTS: MEETING CHALLENGES AND KEEPING PROMISES. Han, Juliana // Harvard Journal of Law & Technology;Spring2007, Vol. 20 Issue 2, p423 

    The article discusses the trends in genetic tests and the current regulatory framework for such tests in the U.S. and explores the constitutional and statutory sources of authority for the U.S. Food and Drug Administration (FDA) oversight of laboratory-developed genetic tests. Unlike genetic...

  • Messing with home brews.  // Nature Biotechnology;Mar2007, Vol. 25 Issue 3, p262 

    Political moves to expand FDA oversight to home brews are a bad idea.

  • PRODUCT BRIEFS.  // Diagnostics & Imaging Week;11/13/2008, Vol. 11 Issue 46, p12 

    This section offers news briefs related to the medicine industry as of November 2008. During the American Society of Nephrology's Renal Week, presentations showed that frequently monitoring hemoglobin during hemodialysis will give physicians information that may lessen hemoglobin variability....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics